1,154 filings
Page 48 of 58
424B3
sc3qclpwt0b4w4k
15 Nov 06
Prospectus supplement
12:00am
8-K
xdkag1575bog
9 Nov 06
Discovery Labs Reports Third Quarter 2006 Financial Results
12:00am
S-8
ghvul cd9ew8
7 Nov 06
Registration of securities for employees
12:00am
8-K
ql8slwp4a 1fnwl
26 Oct 06
Entry into a Material Definitive Agreement
12:00am
424B3
eisz 2n3gmm8
12 Oct 06
Prospectus supplement
12:00am
8-K
tgoo2udp6527mt6b40n
12 Oct 06
Other Events
12:00am
8-K
68g22wd
11 Oct 06
Discovery Labs Announces Topline Results of Surfaxin® Phase 2 Clinical Trial for the Prevention and Treatment of BPD
12:00am
S-8
387zv4
28 Sep 06
Registration of securities for employees
12:00am
8-K
zmr iq0w81t7
28 Sep 06
Discovery Labs Updates Progress on Manufacturing Remediation and Surfaxin® FDA Regulatory Matters
12:00am
8-K
2j239b9wav91hs6
2 Aug 06
Discovery Labs Reports Second Quarter 2006 Financial Results
12:00am
8-K
2c8cjv9 gyzn
27 Jun 06
Discovery Labs Reports Progress on its Surfactant Manufacturing Remediation
12:00am
8-K
rnm61
22 Jun 06
Discovery Labs Retains Jefferies & Company to Assist in the Evaluation of Potential Strategic Alternatives
12:00am
8-K
o7qpzaa2v34k2f2
16 Jun 06
Discovery Labs’ SurfaxinÒ Granted Orphan Drug Designation for the Prevention of Bronchopulmonary Dysplasia
12:00am
8-K
i7tq0fnbo1
7 Jun 06
Other Events
12:00am
424B3
3ebkb2ti043 2e8z5g8
31 May 06
Prospectus supplement
12:00am
8-K
kzgrlu9ngmy
15 May 06
Discovery Labs Reports First Quarter 2006 Financial Results
12:00am
424B3
7o43bplac8dx
12 May 06
Prospectus supplement
12:00am